收藏切换
The implementation process of simulation technology in clinical trials and case practice
收藏切换
PDF
Ruo-bing LI, Jing-zhao WANG, Jun WANG
Chinese Journal of New Drugs | 2023, 32(14) : 1411 - 1416
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(14): 1411-1416
The implementation process of simulation technology in clinical trials and case practice
Full
Ruo-bing LI, Jing-zhao WANG, Jun WANG
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
Published: 2023-07-30
Outline
收藏切换

Simulation technology is an effective tool to improve the success rate of clinical studies, with applications at all stages of clinical research. This paper illustrated the content, requirements, and issues in three parts: simulation plan, implementation, summary, and evaluation. In the case practice of survival analysis, the article assumed a scenario where time-to-event data does not meet the proportional hazards assumption, using an exponential cure rate function model with a delayed effect. The simulation aimed to study trial design factors such as the average hazards ratio, sample size, and number of events. The results demonstrated that non-proportional hazards assumptions significantly impact the trial hypothesis, follow-up time, and analysis time. Using normal trial design methods based on the proportional hazards assumption could lead to reduced test power and unreliable interim analysis results. Simulation technology could better support the design and implementation of clinical trials. Finally, the paper discussed the importance and impact of scenario assumption in simulation implementation and execution. Also, it is pointed out that the complexity of simulation should be considered to improve the feasibility of simulation execution.

simulation technology  /  scenario assumption  /  non-proportional hazards assumption
Ruo-bing LI, Jing-zhao WANG, Jun WANG. The implementation process of simulation technology in clinical trials and case practice[J]. Chinese Journal of New Drugs, 2023 , 32 (14) : 1411 -1416 .
Year 2023 volume 32 Issue 14
PDF
34
9
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-07-30
Article Data
Affiliations
History
  • Accepted:2023-04-04
Affiliations
    Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT